CNN2 silencing inhibits colorectal cancer development through promoting ubiquitination of EGR1

Life Sci Alliance. 2023 May 15;6(7):e202201639. doi: 10.26508/lsa.202201639. Print 2023 Jul.

Abstract

Colorectal cancer (CRC) is one of the most commonly diagnosed malignant tumors of the digestive tract. H2-calponin (CNN2), an actin cytoskeleton-binding protein, is an isoform of the calponin protein family whose role in CRC is still unknown. Research based on clinical samples showed the up-regulation of CNN2 in CRC and its association with tumor development, metastasis, and poor prognosis of patients. Both in vitro loss-of-function and gain-of-function experiments showed that CNN2 participates in CRC development through influencing malignant cell phenotypes. In vivo, xenografts formed by CNN2 knockdown cells also showed a slower growth rate and smaller final tumors. Furthermore, EGR1 was identified as a downstream of CNN2, forming a complex with CNN2 and YAP1 and playing an essential role in the CNN2-induced regulation of CRC development. Mechanistically, CNN2 knockdown down-regulated EGR1 expression through enhancing its ubiquitination, thus decreasing its protein stability in a YAP1-dependent manner. In summary, CNN2 plays an EGR1-dependent promotion role in the development and progression of CRC, which may be a promising therapeutic target for CRC treatment.

MeSH terms

  • Calcium-Binding Proteins / metabolism
  • Calponins
  • Colorectal Neoplasms* / metabolism
  • Early Growth Response Protein 1 / genetics
  • Early Growth Response Protein 1 / metabolism
  • Humans
  • Microfilament Proteins* / genetics
  • Microfilament Proteins* / metabolism
  • Ubiquitination

Substances

  • Microfilament Proteins
  • Calcium-Binding Proteins
  • EGR1 protein, human
  • Early Growth Response Protein 1